Patently Absurd

PATENTLY ABSURD….There’s been a lot of concern lately about the prospect that the BlackBerry might soon be brought down by a “patent troll” ? in this case, a small Virginia company, NTP, which holds a patent on wireless email technology and is now suing RIM, the BlackBerry’s maker, after it refused to pay NTP a licensing fee.

This Slate piece does a good job of capturing the issues in play, but I’d argue with its contention that the problem is confined to the software industry. In fact, over-broad and possibly invalid patents stifle innovation in a range of fields, and the negative human consequences in areas like bio-technology are more immediate, and perhaps more damaging, than in software.

Take breast cancer research. As we reported in the Monthly last year, one company, Myriad Genetics, holds a patent on the study of a gene, BRCA1 known to cause breast cancer. Women who want to get tested for the gene have to go thru Myriad, and pay a much higher price for the test thanks to Myriad’s monopoly. Worse, researchers trying to create a better test, one that could more accurately identify BRCA1, routinely receive cease and desist letters from Myriad’s lawyers. One scientist at U Penn told me she’d moved on to other projects thanks to Myriad constantly hassling her.

Of course, without the incentive of a patent, companies like Myriad wouldn’t conduct life-saving research. But in fact, a consortium of scientists from across the world was working to sequence BRCA1. Myriad’s founder, Mark Skolnick was part of that group, and he used the group’s work as a foundation before crossing the final hurdle himself. No one doubts that, absent Skolnick’s work, the consortium would have got there soon afterwards.

In other words, a crucial area of breast cancer research is now effectively closed off to all but one for-profit company, despite the fact that their “invention” would surely have soon been developed without them. And just as with software patents, at the root of the problem is a patent system that makes patents too easy to acquire and gives patent-holders overly broad rights. Tell me how that promotes innovation again.

Washington Monthly - Donate today and your gift will be doubled!

Support Nonprofit Journalism

If you enjoyed this article, consider making a donation to help us produce more like it. The Washington Monthly was founded in 1969 to tell the stories of how government really works—and how to make it work better. Fifty years later, the need for incisive analysis and new, progressive policy ideas is clearer than ever. As a nonprofit, we rely on support from readers like you.

Yes, I’ll make a donation